Publications by authors named "Marika Colombo"

Claim this Profile
O
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.
Serena Petrella, Marika Colombo, Mirko Marabese, Chiara Grasselli, Andrea Panfili

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2).
Marika Colombo, Federico Passarelli, Paola A Corsetto, Angela M Rizzo, Mirko Marabese

Cells· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1: Can We Target an Hidden Target? Focus on NSCLC.
Gloriana Ndembe, Ilenia Intini, Elisa Perin, Mirko Marabese, Elisa Caiola, Marika Colombo

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models.
Lavinia Morosi, Marina Meroni, Paolo Ubezio, Ilaria Fuso Nerini, Lucia Minoli, Marika Colombo

J Exp Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Cristina Borzi, Monica Ganzinelli, Elisa Caiola, Marika Colombo, Giovanni Centonze

J Thorac Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS Targeting and Resistance: Anticipating the Expectable.
Marika Colombo, Gloriana Ndembe, Massimo Broggini

J Thorac Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of response to PI3K/akt/mTOR and KRAS pathways inhibitors in NSCLC cell lines.
Alice Iezzi, Elisa Caiola, Marika Colombo, Mirko Marabese, Massimo Broggini

Am J Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations.
Marika Colombo, Mirko Marabese, Giulia Vargiu, Massimo Broggini, Elisa Caiola

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation.
Elisa Caiola, Marika Colombo, Giovanna Sestito, Monica Lupi, Mirko Marabese

Cells· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
Elisa Caiola, Alice Iezzi, Michele Tomanelli, Elisa Bonaldi, Arianna Scagliotti, Marika Colombo

J Thorac Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis